Amniotic fluid embolism (AFE) most often occurs during active labor or within 30 minutes of delivery. About 53% of cases present at or just before delivery, while the remaining cases appear on average 19 minutes after delivery. In rare instances, AFE can develop up to 48 hours postpartum. It affects roughly 5 out of every 100,000 deliveries in the United States.
The Most Common Windows for AFE
Around 70% of AFE cases happen during labor itself, making it the single highest-risk period. Another 19% occur during cesarean sections, and about 11% develop after vaginal deliveries. The pattern is consistent: the vast majority of cases cluster tightly around the time of delivery, when the physical barrier between maternal blood and amniotic fluid is most likely to be disrupted.
The postpartum window extends further than many people realize. While most cases strike within minutes of delivery, AFE has been documented up to 48 hours after birth. This means that sudden cardiovascular collapse, difficulty breathing, or heavy bleeding that develops in the first two days after delivery could still be AFE, even though most cases present much sooner.
Less Common Triggers Outside of Delivery
AFE doesn’t happen exclusively during labor and delivery. It can also occur during second-trimester procedures like dilation and evacuation, during amniocentesis, after abdominal trauma to a pregnant woman, or during amnio-infusion (when fluid is introduced into the uterus). Cases have also been reported following injection of concentrated saline solution to induce abortion. These situations are far rarer than labor-related AFE, but they share the same underlying problem: amniotic fluid or fetal material entering the mother’s bloodstream.
What Happens in the Body
AFE unfolds in two overlapping phases once amniotic fluid enters the maternal circulation. The first phase lasts roughly 30 minutes and involves a sharp rise in pressure in the blood vessels of the lungs. The right side of the heart struggles against this sudden resistance, leading to cardiovascular collapse, dangerously low blood pressure, and oxygen deprivation. This is the phase most associated with cardiac arrest.
The second phase involves widespread, uncontrolled bleeding caused by a breakdown of the body’s clotting system, known as disseminated intravascular coagulation (DIC). Interestingly, DIC is actually the more common presentation overall. Japanese researchers have suggested that about two-thirds of AFE cases present primarily as the bleeding type rather than the classic heart-and-lung collapse type. In some cases, the first visible sign is severe postpartum hemorrhage, followed shortly by cardiac instability and seizures from reduced blood flow to the brain.
The underlying mechanism appears to be an immune reaction. Amniotic fluid contains substances that activate the immune system in a way similar to a severe allergic reaction. Fetal material triggers immune cells in the lungs to release inflammatory chemicals, while also activating the clotting cascade throughout the body. This combination of immune overreaction and clotting dysfunction is what makes AFE so dangerous and so fast-moving.
Who Is at Higher Risk
AFE is unpredictable, but certain factors increase the odds. Maternal age over 35 is one of the most consistently identified risk factors, linked to both higher incidence and higher fatality. Other recognized risk factors include cesarean delivery, carrying multiples (twins or more), induced labor, operative vaginal delivery using forceps or vacuum, and excess amniotic fluid (polyhydramnios).
Placental problems also play a role. Placenta previa (where the placenta covers the cervix), placental abruption (where it separates early from the uterine wall), and placenta accreta (where it grows too deeply into the uterine wall) are all associated with AFE. Uterine rupture and abdominal trauma round out the list. The common thread is any condition that makes it easier for amniotic fluid to cross into the mother’s bloodstream.
How It’s Recognized
Because AFE is so rare and strikes so quickly, diagnosis is based on four criteria that must all be present: sudden low blood pressure or cardiac arrest, sudden oxygen deprivation, breakdown of the clotting system or severe hemorrhage that can’t be explained by blood loss alone, and all of this happening during labor, cesarean delivery, or within 30 minutes of delivery with no other explanation. The requirement that clotting problems appear before enough blood has been lost to explain them on its own is what separates AFE from ordinary hemorrhagic shock.
There is no single blood test that confirms AFE in real time. The diagnosis is largely one of exclusion, made when the classic combination of cardiovascular collapse, breathing failure, and coagulopathy appears in the right time window and nothing else accounts for it.
Survival and Outcomes
AFE was once considered almost universally fatal, but outcomes have improved. A 20-year U.S. study covering 2000 to 2019 found an average case-fatality rate of 17.7%, meaning roughly 1 in 5 to 6 women who develop AFE die from it. The incidence rate stayed stable at about 4.9 cases per 100,000 deliveries over that period, but the mortality rate declined, likely reflecting improvements in critical care and faster recognition. For cesarean deliveries specifically, one large study found a mortality rate of 14.9% among women who developed AFE.
Survivors can face serious complications. The period of oxygen deprivation during cardiovascular collapse poses the greatest risk to long-term health, particularly to the brain. The speed of recognition and treatment is the most important factor in determining whether a woman survives and how fully she recovers.